ETC
ONC icon

Exchange Traded Concepts’s BeOne Medicines Ltd ONC Stock Holding History

Exchange Traded Concepts’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-507
Closed -$91.2K – 1430
2023
Q3 		$91.2K Hold
507
– – ﹤0.01% 934
2023
Q2 		$90.4K Buy
+507
New +$117K ﹤0.01% 952
2021
Q1 		– Sell
-2,257
Closed -$583K – 1186
2020
Q4 		$583K Sell
2,257
-286
-11% -$78.7K 0.03% 313
2020
Q3 		$728K Buy
+2,543
New +$598K 0.04% 206

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Exchange Traded Concepts's ONC Position: Q4 2023 in Review

Exchange Traded Concepts sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 507 shares — an estimated $91.2K sold.

Exchange Traded Concepts first reported a position in ONC in Q3 2020 and held it in 4 quarters. The position peaked at $728K in Q3 2020. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • Exchange Traded Concepts reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 507 BeOne Medicines Ltd shares in Q4 2023, an estimated $91.2K.
  • Exchange Traded Concepts first reported a position in BeOne Medicines Ltd in Q3 2020 and held it in 4 quarters.
  • Exchange Traded Concepts's BeOne Medicines Ltd position peaked at $728K in Q3 2020.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Exchange Traded Concepts's 13F filing for Q4 2023, filed 5 Jan 2024.